Expression data from Rembrandt database indicated that MTFR2 was significantly elevated in GBM samples when compared to other subtypes of glioma or normal brain tissue (Supplementary Figure 3A) and higher MTFR2 expression could be correlated with poor prognosis (Supplementary Figure 3B). Here, MTFR2 is linked to central nervous system cancer.